Alpha 2.0
Login Register
» Authors » Wouter B Nagengast

Wouter B Nagengast

Explore the profile of Wouter B Nagengast including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 83
Citations 1959
Followers 0
Related Specialties
Gastroenterology
Radiology
Oncology
Top 10 Co-Authors
Gooitzen M van Dam
Bas L A M Weusten
Roos E Pouw
Alaa Alkhalaf
Elisabeth G E de Vries
Martin H M G Houben
Jessie Westerhof
Lorenza Alvarez Herrero
Arjun D Koch
Jacques J G H M Bergman
Published In
J Nucl Med
Endoscopy
Gastroenterology
Gut
Gastrointest Endosc
Affiliations
Soon will be listed here.
Recent Articles
11.
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessment
van Tilburg L, Verheij E, van de Ven S, van Munster S, Weusten B, Alvarez Herrero L, et al.
Endoscopy . 2024 Feb; 56(8):559-568. PMID: 38378018
Background:  This study evaluated the proportion of patients with residual neoplasia after endoscopic resection (ER) for Barrett's neoplasia with confirmed tumor-positive vertical resection margin (R1v). Methods:  This retrospective cohort study...
12.
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial
Goltstein L, Grooteman K, Bernts L, Scheffer R, Laheij R, Gilissen L, et al.
Gastroenterology . 2023 Dec; 166(4):690-703. PMID: 38158089
Background & Aims: Gastrointestinal angiodysplasias are vascular anomalies that may result in transfusion-dependent anemia despite endoscopic therapy. An individual patient data meta-analysis of cohort studies suggests that octreotide decreases rebleeding...
13.
Robot-assisted fluorescent sentinel lymph node identification in early-stage colon cancer
Sikkenk D, Sterkenburg A, Burghgraef T, Akol H, Schwartz M, Arensman R, et al.
Surg Endosc . 2023 Sep; 37(11):8394-8403. PMID: 37721591
Background: Patients with cT1-2 colon cancer (CC) have a 10-20% risk of lymph node metastases. Sentinel lymph node identification (SLNi) could improve staging and reduce morbidity in future organ-preserving CC...
14.
EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial
de Wit J, Vonk J, Voskuil F, de Visscher S, Schepman K, Hooghiemstra W, et al.
Nat Commun . 2023 Aug; 14(1):4952. PMID: 37587149
Inadequate surgical margins occur frequently in oral squamous cell carcinoma surgery. Fluorescence molecular imaging (FMI) has been explored for intraoperative margin assessment, but data are limited to phase-I studies. In...
15.
Nationwide practice in CT-based preoperative staging of colon cancer and concordance with definitive pathology
Sikkenk D, Sijmons J, Burghgraef T, Asaggau I, Vos A, da Costa D, et al.
Eur J Surg Oncol . 2023 Jul; 49(10):106941. PMID: 37442716
Introduction: In an era of exploring patient-tailored treatment options for colon cancer, preoperative staging is increasingly important. This study aimed to evaluate completeness and reliability of CT-based preoperative locoregional colon...
16.
Detection of Tumour-Targeted IRDye800CW Tracer with Commercially Available Laparoscopic Surgical Systems
Sikkenk D, Sterkenburg A, Schmidt I, Gorpas D, Nagengast W, Consten E
Diagnostics (Basel) . 2023 May; 13(9). PMID: 37174982
(1) Introduction: Near-infrared fluorescence (NIRF) combined with tumour-targeted tracers, such as bevacizumab-800CW, could aid surgical decision-making. This study explored the use of IRDye800CW, conjugated to bevacizumab, with four commercially available...
17.
Towards a robust and compact deep learning system for primary detection of early Barrett's neoplasia: Initial image-based results of training on a multi-center retrospectively collected data set
Fockens K, Jukema J, Boers T, Jong M, van der Putten J, Pouw R, et al.
United European Gastroenterol J . 2023 Apr; 11(4):324-336. PMID: 37095718
Introduction: Endoscopic detection of early neoplasia in Barrett's esophagus is difficult. Computer Aided Detection (CADe) systems may assist in neoplasia detection. The aim of this study was to report the...
18.
Optical Biopsy of Dysplasia in Barrett's Oesophagus Assisted by Artificial Intelligence
van der Laan J, van der Putten J, Zhao X, Karrenbeld A, Peters F, Westerhof J, et al.
Cancers (Basel) . 2023 Apr; 15(7). PMID: 37046611
Optical biopsy in Barrett's oesophagus (BE) using endocytoscopy (EC) could optimize endoscopic screening. However, the identification of dysplasia is challenging due to the complex interpretation of the highly detailed images....
19.
Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW
Gabriels R, van Heijst L, Hooghiemstra W, van der Waaij A, Kats-Ugurlu G, Karrenbeld A, et al.
J Nucl Med . 2023 Jan; 64(5):803-808. PMID: 36604181
Esophageal adenocarcinoma causes 6% of cancer-related deaths worldwide. Near-infrared fluorescence molecular endoscopy (NIR-FME) uses a tracer that targets overexpressed proteins. In this study, we aimed to investigate the feasibility of...
20.
Clinical Relevance of Random Biopsies From the Esophagogastric Junction After Complete Eradication of Barrett's Esophagus is Low
Frederiks C, van Munster S, Nieuwenhuis E, Alvarez Herrero L, Alkhalaf A, Schenk B, et al.
Clin Gastroenterol Hepatol . 2022 Nov; 21(9):2260-2269.e9. PMID: 36423874
Background & Aims: Although random histological sampling from the esophagogastric junction (EGJ) after complete eradication of Barrett's esophagus (BE) is recommended, its clinical relevance is questionable. This study aimed to...